Showing results (411-420 of 442) with videos related to
Sort By:
Pageof 45
BMJ Open|March 3, 2025
Prospective harmonisation of four international randomised controlled trials in Canada, China, India and South Africa: the Healthy Life Trajectories InitiativeJulie Bergeron, Anouar Nechba, Samuel El Bouzaïdi Tiali, et al.Molecular Psychiatry|February 16, 2026
Dynamic interactions between gut microbiome and host lipidome in antenatal depression: a large longitudinal studyFan Li, Yunhaonan Yang, Yuanqing Fu, et al.Internal Medicine Journal|January 12, 2017
Treatment of patients with Waldenström macroglobulinaemia: clinical practice guidelines from the Myeloma Foundation of Australia Medical and Scientific Advisory GroupDipti Talaulikar, Constantine S Tam, Douglas Joshua, et al.The American Journal of Clinical Nutrition|March 13, 2025
Individualized nutritional intervention compared with routine care for gestational diabetes prevention: a randomized controlled trialLulu Wang, Xipeng Wang, Rong Zhang, et al.Internal Medicine Journal|October 19, 2021
Imaging of patients with multiple myeloma and associated plasma cell disorders: consensus practice statement by the Medical Scientific Advisory Group to Myeloma AustraliaKatherine Creeper, Bradley Augustson, Kieran Kusel, et al.Hemasphere|October 15, 2021
Management and Outcomes of Diffuse Large B-cell Lymphoma Post-transplant Lymphoproliferative Disorder in the Era of PET and Rituximab: A Multicenter Study From the Australasian Lymphoma AllianceStephen Boyle, Joshua W D Tobin, Jacinta Perram, et al.Bone Marrow Transplantation|April 29, 2021
The association of mobilising regimen on immune reconstitution and survival in myeloma patients treated with bortezomib, cyclophosphamide and dexamethasone induction followed by a melphalan autograftMatthew J Rees, Peter Mollee, Jun Yen Ng, et al.Transplantation and Cellular Therapy|November 15, 2021
Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell TransplantationSurbhi Sidana, Shaji Kumar, Raphael Fraser, et al.Nature Communications|September 25, 2021
Artificial intelligence system reduces false-positive findings in the interpretation of breast ultrasound examsYiqiu Shen, Farah E Shamout, Jamie R Oliver, et al.Transplantation and Cellular Therapy|March 30, 2021
Bortezomib-Based Induction Is Associated with Superior Outcomes in Light Chain Amyloidosis Patients Treated with Autologous Hematopoietic Cell Transplantation Regardless of Plasma Cell BurdenRobert F Cornell, Raphael Fraser, Luciano Costa, et al.Pageof 45